VBI Vaccines Inc. (VBIV)

VBI Vaccines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	17	14	101	602	666	246
Market Cap Growth	-81.76%	-86.22%	-83.22%	-9.55%	170.59%	138.80%
Enterprise Value	55	43	91	512	564	218
PE Ratio	-	-0.15	-0.89	-8.63	-14.40	-4.49
PS Ratio	1.80	1.60	93.35	954.19	627.38	110.76
PB Ratio	-2.61	1.85	1.57	4.18	3.88	2.79
P/FCF Ratio	-0.28	-0.23	-1.29	-14.37	-13.85	-4.70
P/OCF Ratio	-0.28	-0.23	-1.37	-15.09	-14.15	-5.05
EV/Sales Ratio	5.85	4.98	83.73	811.72	531.98	98.19
EV/EBITDA Ratio	-0.71	-0.51	-0.84	-8.11	-13.48	-4.24
EV/EBIT Ratio	-0.69	-0.50	-0.83	-7.88	-12.97	-4.14
EV/FCF Ratio	-1.02	-0.70	-1.16	-12.22	-11.75	-4.16
Debt / Equity Ratio	-9.28	7.05	0.81	0.22	0.10	0.18
Debt / EBITDA Ratio	-0.68	-0.63	-0.49	-0.50	-0.43	-0.32
Debt / FCF Ratio	-0.99	-0.86	-0.67	-0.76	-0.37	-0.31
Quick Ratio	0.17	0.31	1.70	3.73	6.87	1.49
Current Ratio	0.34	0.48	2.10	4.00	7.61	1.58
Asset Turnover	0.11	0.09	0.01	0.00	0.01	0.02
Interest Coverage	-11.22	-13.50	-27.28	-13.74	-16.07	-23.96
Return on Equity (ROE)	-1094.90%	-462.40%	-118.30%	-42.80%	-34.30%	-62.90%
Return on Assets (ROA)	-95.60%	-92.80%	-65.40%	-31.60%	-27.30%	-44.30%
Return on Capital (ROIC)	-159.48%	-131.94%	-70.30%	-38.73%	-23.01%	-50.11%
Earnings Yield	-496.32%	-674.31%	-112.18%	-11.59%	-6.95%	-22.28%
FCF Yield	-304.22%	-443.72%	-77.26%	-6.96%	-7.22%	-21.30%
Buyback Yield / Dilution	-185.59%	-80.90%	-1.30%	-16.80%	-82.73%	-81.95%
Total Shareholder Return	-185.59%	-80.90%	-1.30%	-16.80%	-82.73%	-81.95%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).